QC
EVMN

Quadrature Capital’s Evommune Inc EVMN Stock Holding History

Quadrature Capital’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$921K Buy
+69,311
New +$1.61M 0.01% 770

Other funds holding EVMN

AP
Andera Partners Paris $206M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Quadrature Capital's EVMN Position: Q2 2026 in Review

Quadrature Capital opened a new position in Evommune Inc (EVMN) in Q2 2026: 69,311 shares worth $921K. The stake represents 0.01% of the portfolio and ranks #770 among its holdings.

21 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Quadrature Capital held 69,311 shares of Evommune Inc worth $921K as of Q2 2026.
  • Evommune Inc was a new Quadrature Capital position in Q2 2026.
  • Evommune Inc made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #770 holding.
  • 21 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.